Meloxicam and Relafen are two medications often prescribed for the treatment of pain and inflammation associated with various conditions, including arthritis and other musculoskeletal disorders. Both drugs belong to the class of nonsteroidal anti-inflammatory drugs (NSAIDs), which are commonly used to alleviate discomfort and improve quality of life for individuals suffering from chronic pain. While they serve similar purposes, there are distinct differences in their mechanisms of action, effectiveness, side effects, and usage guidelines that can influence a patient’s choice of treatment. Understanding these differences is crucial for both healthcare providers and patients in making informed decisions about pain management. With the rising awareness of the importance of personalized medicine,…